Bone Cement Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative and qualitative market trends within Orthopedic Devices therapeutic area.
Bone cement is a fixing material used to fill in spaces between an orthopedic prosthesis and the bone stock. Bone cement helps restore functionality, provides elasticity to the zone between the prosthesis and the bone stock and maintains the mechanical stability of the prosthesis.
Bone cement is composed of two components: PMMA (Polymethyl methacrylate) amorphous powder and MMA (methyl methacrylate) liquid stabilizer. This category includes both antibiotic and nonantibiotic bone cement. Increased prevalence of osteoarthritis (OA), rheumatoid arthritis (RA), and osteoporosis, and growing fracture incidence are contributing to an increased need for bone cement.
Each of the covered 39 countries color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. The interactive excel deliverable covers value, volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insights offer context for quantitative data.
Companies covered: DePuy Synthes Inc, DJO Global Inc, Heraeus Medical GmbH, Stryker Corp, Tecres SPA, Zimmer Biomet Holdings Inc, Smith & Nephew Plc, Cardinal Health Inc and Others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
Bone cement is a fixing material used to fill in spaces between an orthopedic prosthesis and the bone stock. Bone cement helps restore functionality, provides elasticity to the zone between the prosthesis and the bone stock and maintains the mechanical stability of the prosthesis.
Bone cement is composed of two components: PMMA (Polymethyl methacrylate) amorphous powder and MMA (methyl methacrylate) liquid stabilizer. This category includes both antibiotic and nonantibiotic bone cement. Increased prevalence of osteoarthritis (OA), rheumatoid arthritis (RA), and osteoporosis, and growing fracture incidence are contributing to an increased need for bone cement.
Each of the covered 39 countries color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. The interactive excel deliverable covers value, volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insights offer context for quantitative data.
Key Inclusions of the market model are :
Currently marketed Bone Cement Devices and evolving competitive landscape :
- Insightful review of the key industry trends.
- Annualized total Bone Cement Devices market revenue by segment and market outlooks from 2015-2033.
- Granular data on total procedures, units, average selling prices and market values by segment.
Global, Regional and Country level market specific insights :
- Qualitative market specific information is available with global trends further broken down into regional trends. In addition the analyst analysts provide unique country specific insights on the market.
- SWOT analysis for Bone Cement Devices market.
- Competitive dynamics insights and trends provided for Bone Cement Devices market.
- Country specific overview of the healthcare system.
- Country specific reimbursement policies.
- Country specific medtech regulatory landscape.
Companies covered: DePuy Synthes Inc, DJO Global Inc, Heraeus Medical GmbH, Stryker Corp, Tecres SPA, Zimmer Biomet Holdings Inc, Smith & Nephew Plc, Cardinal Health Inc and Others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
Scope
This Market Model gives important, expert insight you won’t find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for :- CMO executives who must have deep understanding of the Bone Cement marketplace to make strategic planning and investment decisions.
- Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
- Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.
Reasons to Buy
The model will enable you to :
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products, by identifying key companies.
- Develop business strategies by understanding the trends shaping and driving Bone Cement market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Bone Cement market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Track device sales in the global and country-specific Bone Cement market from 2015-2033.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- DePuy Synthes Inc
- DJO Global Inc
- Heraeus Medical GmbH
- Stryker Corp
- Tecres SPA
- Zimmer Biomet Holdings Inc
- Smith & Nephew Plc
- Cardinal Health Inc